Dyadic International Inc. (DYAI) vs Pluri Inc. (PLUR)

Dyadic International Inc. and Pluri Inc. are both Biotechnology companies. Dyadic International Inc. and Pluri Inc. are of similar size ($14.0M and $13.7M). Pluri Inc. grew revenue faster over the last twelve months: 10.0% against −7.64%. Dyadic International Inc. has the higher net margin (−226.9% vs −1,943.9%) and the higher return on invested capital (0.00% vs −690.2%). Across the 17 metrics below, Dyadic International Inc. leads on 10 and Pluri Inc. on 7.

Valuation

Metric DYAI PLUR Biotechnology median
P/E n/m n/m 11.36
P/S 3.97 9.01 9.12
P/B n/m n/m 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 4.09 23.14 8.56
Earnings yield (65.63%) (245.37%) (34.18%)
Free cash flow yield (58.32%) (146.92%) (23.62%)

Profitability

Metric DYAI PLUR Biotechnology median
Gross margin 17.85% 51.95% 67.24%
Operating margin (237.12%) (2,341.12%) 0.00%
Net margin (226.87%) (1,943.87%) 0.00%
Free cash flow margin (227.93%) (1,282.11%) 0.00%
Return on equity (47,310.78%) 253.49% (50.28%)
Return on assets (71.43%) (96.79%) (45.89%)
Return on invested capital 0.00% (690.21%) 0.00%

Growth

Metric DYAI PLUR Biotechnology median
Revenue growth (TTM) (7.64%) 10.03% 6.96%
EPS growth (last fiscal year) (15.00%) 31.46% 29.86%
Revenue growth, 5-year CAGR 14.04% 113.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI PLUR Biotechnology median
Debt to equity 0.00 (1.65) 0.00
Current ratio 1.69 0.27 4.72
Net debt to EBITDA 0.49 (0.83) 1.01

Dividend

Metric DYAI PLUR Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric DYAI PLUR Biotechnology median
Market cap 14.02m 13.74m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack